Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies
出版年份 2014 全文链接
标题
Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies
作者
关键词
-
出版物
Molecular Oncology
Volume 9, Issue 1, Pages 309-322
出版商
Wiley
发表日期
2014-09-07
DOI
10.1016/j.molonc.2014.08.010
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Molecular mechanisms of the antitumor activity of SB225002: A novel microtubule inhibitor
- (2013) Ahmed E. Goda et al. BIOCHEMICAL PHARMACOLOGY
- Total cost comparison in relapsed/refractory multiple myeloma
- (2013) Brian Durie et al. JOURNAL OF MEDICAL ECONOMICS
- Redox signaling loops in the unfolded protein response
- (2012) Arisa Higa et al. CELLULAR SIGNALLING
- Dipyridamole prevents triple-negative breast-cancer progression
- (2012) Daniela Spano et al. CLINICAL & EXPERIMENTAL METASTASIS
- Bidirectional crosstalk between endoplasmic reticulum stress and mTOR signaling
- (2012) Christian Appenzeller-Herzog et al. TRENDS IN CELL BIOLOGY
- Bortezomib Primes Glioblastoma, Including Glioblastoma Stem Cells, for TRAIL by Increasing tBid Stability and Mitochondrial Apoptosis
- (2011) T. Unterkircher et al. CLINICAL CANCER RESEARCH
- Molecular Pathways: BCR-ABL
- (2011) D. Cilloni et al. CLINICAL CANCER RESEARCH
- Bortezomib as the First Proteasome Inhibitor Anticancer Drug: Current Status and Future Perspectives
- (2011) D. Chen et al. CURRENT CANCER DRUG TARGETS
- Blockade of JAK2-mediated extrinsic survival signals restores sensitivity of CML cells to ABL inhibitors
- (2011) E Traer et al. LEUKEMIA
- BID Binds to Replication Protein A and Stimulates ATR Function following Replicative Stress
- (2011) Y. Liu et al. MOLECULAR AND CELLULAR BIOLOGY
- Hypoxia Selects Bortezomib-Resistant Stem Cells of Chronic Myeloid Leukemia
- (2011) Michele Tanturli et al. PLoS One
- Enhancing activity and overcoming chemoresistance in hematologic malignancies with bortezomib: preclinical mechanistic studies
- (2010) N. Reddy et al. ANNALS OF ONCOLOGY
- JAK2 activation in myeloproliferative neoplasms: A potential role for heterodimeric receptors
- (2010) Gary W. Reuther CELL CYCLE
- The BCL-2 Family Reunion
- (2010) Jerry E. Chipuk et al. MOLECULAR CELL
- Phase I and Pharmacokinetic Study of Bortezomib in Combination with Idarubicin and Cytarabine in Patients with Acute Myelogenous Leukemia
- (2008) E. C. Attar et al. CLINICAL CANCER RESEARCH
- Mechanisms of proteasome inhibitor action and resistance in cancer
- (2008) David J. McConkey et al. DRUG RESISTANCE UPDATES
- Interferon-γ Induces X-linked Inhibitor of Apoptosis-associated Factor-1 and Noxa Expression and Potentiates Human Vascular Smooth Muscle Cell Apoptosis by STAT3 Activation
- (2008) Yalai Bai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapy
- (2008) J A McCubrey et al. LEUKEMIA
- Mechanisms of enhancement of TRAIL tumoricidal activity against human cancer cells of different origin by dipyridamole
- (2008) A E Goda et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now